(NASDAQ: SENS) Senseonics Holdings's forecast annual revenue growth rate of 29.79% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.59%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.47%.
Senseonics Holdings's revenue in 2026 is $48,545,000.On average, 9 Wall Street analysts forecast SENS's revenue for 2026 to be $3,350,047,124, with the lowest SENS revenue forecast at $3,140,084,260, and the highest SENS revenue forecast at $3,547,584,586. On average, 10 Wall Street analysts forecast SENS's revenue for 2027 to be $5,149,033,903, with the lowest SENS revenue forecast at $4,307,384,728, and the highest SENS revenue forecast at $7,039,651,416.
In 2027, SENS is forecast to generate $5,320,715,953 in revenue, with the lowest revenue forecast at $4,544,313,359 and the highest revenue forecast at $7,084,065,621.